New aspects of the mechanism of corticosteroid-induced dermal atrophy
- PMID: 1806315
- DOI: 10.1111/j.1365-2230.1991.tb01225.x
New aspects of the mechanism of corticosteroid-induced dermal atrophy
Abstract
Glucocorticoids are effective for the treatment of various inflammatory skin diseases, but their long-term use may lead to serious side-effects such as osteoporosis and skin atrophy. The incidence of skin atrophy following application of potent corticosteroids is especially high among children and the elderly. During recent years the effects of glucocorticoids on connective tissue have been elucidated, and it is evident that skin atrophy is mostly due to a decrease in collagen synthesis. Since collagen is the most abundant protein in the skin, the inhibition of its synthesis leads to atrophy. This review discusses the molecular mechanisms of glucocorticosteroid-induced skin atrophy and therapeutic possibilities.
Similar articles
-
Evaluation of the atrophogenic potential of different glucocorticoids using optical coherence tomography, 20-MHz ultrasound and profilometry; a double-blind, placebo-controlled trial.Br J Dermatol. 2006 Oct;155(4):700-6. doi: 10.1111/j.1365-2133.2006.07369.x. Br J Dermatol. 2006. PMID: 16965418 Clinical Trial.
-
Local atrophy of the cheek skin and hirsutism in a 3-year-old child following corticosteroids treatment.Ann Univ Mariae Curie Sklodowska Med. 2003;58(1):227-30. Ann Univ Mariae Curie Sklodowska Med. 2003. PMID: 15314990
-
Perilesional linear atrophy and hypopigmentation after intralesional corticosteroid therapy. Report of two cases and review of the literature.J Am Acad Dermatol. 1988 Sep;19(3):537-41. doi: 10.1016/s0190-9622(88)70209-1. J Am Acad Dermatol. 1988. PMID: 3049699 Review.
-
Skin atrophy of the eyelid induced by topical ophthalmic corticosteroids.Acta Ophthalmol Scand. 1998 Jun;76(3):372-3. doi: 10.1034/j.1600-0420.1998.760326.x. Acta Ophthalmol Scand. 1998. PMID: 9686858
-
Glucocorticoid therapy-induced skin atrophy.Exp Dermatol. 2006 Jun;15(6):406-20. doi: 10.1111/j.0906-6705.2006.00435.x. Exp Dermatol. 2006. PMID: 16689857 Review.
Cited by
-
Inhibition of glucocorticoid-induced epidermal and dermal atrophy with KH 1060--a potent 20-epi analogue of 1,25-dihydroxyvitamin D3.Br J Pharmacol. 1994 Oct;113(2):439-44. doi: 10.1111/j.1476-5381.1994.tb17008.x. Br J Pharmacol. 1994. PMID: 7834193 Free PMC article.
-
A view on the skin-bone axis: unraveling similarities and potential of crosstalk.Front Med (Lausanne). 2024 Mar 4;11:1360483. doi: 10.3389/fmed.2024.1360483. eCollection 2024. Front Med (Lausanne). 2024. PMID: 38500951 Free PMC article. Review.
-
Molecular mechanisms and treatment strategies for Dupuytren's disease.Ther Clin Risk Manag. 2010 Sep 7;6:383-90. doi: 10.2147/tcrm.s9165. Ther Clin Risk Manag. 2010. PMID: 20856684 Free PMC article.
-
Mechanisms of action of topical corticosteroids in psoriasis.Int J Endocrinol. 2012;2012:561018. doi: 10.1155/2012/561018. Epub 2012 Nov 5. Int J Endocrinol. 2012. PMID: 23213332 Free PMC article.
-
Glucocorticoids induce senescence in primary human tenocytes by inhibition of sirtuin 1 and activation of the p53/p21 pathway: in vivo and in vitro evidence.Ann Rheum Dis. 2014 Jul;73(7):1405-13. doi: 10.1136/annrheumdis-2012-203146. Epub 2013 Jun 1. Ann Rheum Dis. 2014. PMID: 23727633 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical